We invite you to join us in the spectacular city of Barcelona, Spain for the 11th European Congress on Hematologic Malignancies: From Clinical Science to Clinical Practice which will be held 13-15 March 2015.
Given the rapid pace of research in this field, it is essential for our community to stay informed of the latest findings and their potential impact on our clinical practice. Advances in our understanding of the mechanisms of hematologic malignancies have not only resulted in novel therapies and improvements in disease management—such as maintenance strategies and new and improved regimens involving targeted therapies, proteasome inhibitors, monoclonal antibodies, and immunomodulatory agents—but have also given rise to new challenges and debates.
The European Congress on Hematologic Malignancies has provided cutting-edge updates and expert perspectives on the diagnosis and management of hematologic malignancies, including multiple myeloma, chronic lymphocytic leukemia, and Hodgkin’s and non-Hodgkin’s lymphomas. By combining stimulating didactic sessions, interactive panel discussions, and lively debates by internationally renowned specialists, this Congress continues to provide healthcare professionals with the information they need to optimize care and outcomes for their patients with hematologic malignancies.
To complement the exceptional scientific experience of this Congress, Barcelona, the second largest city in Spain, offers the perfect educational backdrop, with its unique culture and history.
We hope you will join us in this beautiful and historic city for what is sure to be an exciting, interactive and educational experience.
Regards,
Bertand Coiffier, MD
Eva Kimby, MD, PhD
EACCME Accreditation
The Congress has applied for accreditation by the European Accreditation Council for Continuing Medical Education (EACCME). Attendees will receive a link to a certificate of attendance at the end of the Congress.
The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.
Who Should Attend
This educational activity is specifically designed for medical oncologists, hematologists, and other healthcare professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physicians’ assistants, etc.) involved and/or interested in the therapeutic management of patients with hematologic malignancies.
